Archive for the ‘pharmaceutical stocks’ Category

« Older Entries

Acura Pharmaceuticals (ACUR) rides FDA OK to stock surge

Monday, June 20th, 2011

Acura Pharmaceuticals (Nasdaq: ACUR) rose 19.4% to $4.62 on Monday, soon after the company said the U.S. Food and Drug Administration (FDA) had approved a pain treatment owned by Acura and Pfizer Inc. Volume for Acura stock topped 4.3 million, towering over a daily average of just below 168,000.

OXECTA is the first immediate-release oxycodone HCl medicine that applies technology designed to discourage common methods of tampering associated with opioid abuse and misuse. This AVERSION® Technology is a unique composition of commonly used pharmaceutical ingredients. Pfizer is licensing the technology in OXECTA from Acura.

Opioid medications are an important treatment option for patients with moderate to severe pain who are not adequately managed by other pain treatments. However, abuse and misuse of opioids is a serious public health issue that is the focus of a number of recent United States government initiatives.

In the June 20 press release trumpeting the approval from the federal body, interim Acura CEO Robert Jones said, “we are excited to be partnered with Pfizer to bring OXECTA to patients who need opioids to manage their pain. Acura is focused on developing technologies that are intended to potentially deter abuse and misuse.”

Based in Palatine, Ill., Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in research, development and commercialization of product candidates intended potentially to deter abuse and misuse utilizing its proprietary AVERSION® and IMPEDE® technologies.

Tags: , , ,
Posted in pharmaceutical stocks | No Comments »

TGLO skyrockets, LFBG leads volume pack, MITD bruised

Wednesday, December 15th, 2010

TheGlobe.com Inc. (OTCBB: TGLO) shot out of the gates Wednesday like a rocket, gaining 133.33 percent to 28-100ths of a cent. Volume was 49,000 shares, better than half its volume of 82,865 on an average day.

Left Behind Games Inc. (OTCBB: LFBG) tumbled off the shelves Wednesday, trading in 57.38 million shares, catching up on its full-day average of 93.65 million. Prices fell, though, by 15.38 percent to 33-100ths of a cent. The company sells games and videos with a Christian theme.

MIT Holding Inc. (OTCBB: MITD) stumbled 65 percent in price to seven-10ths of a cent, on volume of 124,500 shares, more than 10 times its full-day average. The Company, through its three wholly-owned subsidiaries, distributes wholesale pharmaceuticals, administers intravenous infusions, operates an ambulatory center where therapies are administered, and sells and rents home medical equipment.

Tags: , , , , , ,
Posted in Consumer Discretionary Stocks, pharmaceutical stocks, Technology Stocks | No Comments »

CYPB spreads wings, C solid, MOTR in reverse

Wednesday, December 15th, 2010

Cypress Bioscience (NasdaqGM: CYPB) jumped 12.2% to$6.45, on volume of 8,570,704, or 16 times its full-day average, after it agreed to be acquired by Ramius LLC and Royalty Pharma for about $255 million in cash, ending a takeover battle that began in July.

Citigroup (NYSE: C) traded in 155,455,525 shares, making good headway on its daily average of 539,270,000 shares. Share prices retreated 0.53 per cent, however, Wednesday, to $4.66.

Motricity Inc. (NasdaqGM: MOTR) backtracked 13.53 percent in Wednesday morning trading at $18.40. Volume of 3,277,545 shares tramped its full-day average of 559,200. MOTR, based in Bellevue, Wash., is a leading mobile data solutions provider exclusively focused on the rapidly growing mobile Internet market.

Tags: , , , , , , , ,
Posted in Financial Stocks, pharmaceutical stocks, Technology Stocks | No Comments »

CRMD healthy, F rolls off lot, PWAV subsides

Monday, December 13th, 2010

CorMedix Inc. (AMEX: CRMD) boosted its price 18.31 percent to close Monday’s trading at $1.68. Volume for the stock was 85,819 shares, or about seven times its normal daily average. CRMD is a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease

Ford Motor Company (NYSE: F) traded in 52,625,749 shares, but still a whole lot less than its daily average of 84,557,800 shares. Share prices retreated 1.55 percent to $16.47. Ford said Monday it will begin construction on a new plant in Nanchang City, capital of east China’s Jiangxi Province, next year.

Powerwave Technologies Inc. (NasdaqGS: PWAV) backtracked 11.48 percent to close Monday at $2.39. Volume of 5,798,434 shares, more than tripled its full-day average. The company is a global leader in end-to-end wireless coverage and capacity solutions.

Tags: , , , , , , , , ,
Posted in Consumer Discretionary Stocks, pharmaceutical stocks, Technology Stocks | No Comments »

CRDC in gear, INTC busy trader, ENMD drops

Monday, December 13th, 2010

Cardica Inc. (NasdaqGM: CRDC) rocketed up 23.49 percent mid-afternoon Monday to $3.47. Volume for the stock was 630,521 shares, or more than 10 times its normal daily average. CRDC designs and manufactures proprietary stapling and anastomotic devices for cardiac and endoscopic surgical procedures.

Intel Corp. (NasdaqGS: INTC) traded in 56,971,125 shares, closing in on Intel’s its normal daily average of 59,805,000. Prices for the chipmaker tailed off a bit, though, 1.87 percent to $21.50.

EntreMed Inc. (NasdaqCM: ENMD) moved earthward 7.35 percent to $5.04 on Monday afternoon. Volume was 206,151 shares, more than double its full-day average. ENMD, based in Rockville, Md., is a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer

Tags: , , , , , , ,
Posted in Health Care Stocks, pharmaceutical stocks, Technology Stocks | No Comments »

« Older Entries